Table 3.
Outcome.
Covered (20) | Uncovered (25) | |
---|---|---|
Median follow-up,months | 57 (12–129) | 35 (14–86) |
Upper limb/lower limb BP gradient > 10 mm Hg | 3 | 1 |
Mean number of anti-hypertensives | 1.38 ± 0.74 | 1 + 0.7 |
Imaging on follow-up | 18 | 8 |
Late lumen loss | ||
No or mild | 2 (Advanta 1, CP 1) | 4 (CP 3, Palmaz 1) |
Moderate | 12 (Advanta 7, CP 4, Andra 1) | 4 (CP3, Palmaz 1) |
Severe | 4 (Advanta 3, CP 1) | 0 |
Strut fracture | 1 (Advanta) | 0 |